GalChimia is happy to be part of a collaborative effort to boost EU Synthetic Biology competitiveness
January 17, 2019 · R&DAn 8 million Euros grant was attributed by the EU to the ShikiFactory100 project, an international effort coordinated by biotech SME SilicoLife, in cooperation with some of the most relevant players in Europe, covering leading research institutions, SMEs and a large industrial company.
Read More
Resultados del proyecto Mytitox
July 2, 2018 · Made in GalChimia, R&DDuring the project, the synthesis of a COF (Covalent Organic Framework), capable of being used to capture toxins in the marine environment to predict toxic episodes, has been scaled.
Read More
Resultados del proyecto NEOGALFARM
July 2, 2018 · Made in GalChimia, R&DYa están publicados los resultados del Proyecto NEOGALFARM, centrado en la búsqueda de nuevos fármacos para el tratamiento contra el cáncer mediante el desarrollo de terapias dirigidas a diferentes dianas terapéuticas y de tratamientos combinados. ¡Consúltalos aquí!
Read More
Update on Mytitox project
May 11, 2018 · Made in GalChimia, R&DNew updates on Mytitox Project. All the information here!
Read More
How is GalChimia’s R&D going?
February 8, 2018 · Made in GalChimia, R&DGalchimia’s R&D activities in 2018 will focus on four projects: Nanofacturing, Biogreen, Neogalfarm and Mytitox.
Read More